O. Pipek

发表

Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma

Z. Szallasi, B. Döme, L. Reiniger, 2019, Acta oncologica.

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Zoltan Szallasi, Ashish Chandra, Adam Huffman, 2018, Cell.

Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions

I Csabai, Z. Szallasi, I. Csabai, 2016, Oncogene.

Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions

I Csabai, Z. Szallasi, I. Csabai, 2016, Oncogene.

The genomic imprint of cancer therapies helps timing the formation of metastases

Z. Szallasi, I. Csabai, L. Reiniger, 2019, International journal of cancer.

Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with

Z. Szallasi, I. Csabai, G. Tusnády, 2017 .

The Genome of the Chicken DT40 Bursal Lymphoma Cell Line

Gábor E. Tusnády, Zoltan Szallasi, István Csabai, 2014, G3: Genes, Genomes, Genetics.

A comprehensive survey of the mutagenic impact of common cancer cytotoxics

Gábor E. Tusnády, Zoltan Szallasi, István Csabai, 2016, Genome Biology.

Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts

Z. Szallasi, I. Csabai, Yonghong Xiao, 2018, British Journal of Cancer.

The landscape of small cell lung cancer metastases: Organ specificity and timing

O. Pipek, J. Moldvay, M. Rezeli, 2021, Thoracic cancer.

Worldwide human mitochondrial haplogroup distribution from urban sewage

R. Kaas, F. Aarestrup, M. Koopmans, 2019, Scientific Reports.

PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis.

Z. Szallasi, B. Döme, L. Reiniger, 2019, Clinical lung cancer.

S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression

I. Csabai, A. Kalmár, B. Molnár, 2020, Cells.

EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study

Z. Szallasi, V. Téglási, O. Pipek, 2021, Translational lung cancer research.

Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

Z. Szallasi, B. Döme, L. Reiniger, 2018, Journal of Cancer Research and Clinical Oncology.

New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study.

Z. Szallasi, I. Csabai, B. Döme, 2018, Lung cancer.

Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis

Z. Szallasi, C. Swanton, B. Döme, 2017, Neuro-oncology.

Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts

Z. Szallasi, I. Csabai, Yonghong Xiao, 2018, British Journal of Cancer.

FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic Mice

I. Csabai, O. Pipek, V. Müller, 2020, Frontiers in Immunology.

A genetikai adatok szerepe a járványok elleni küzdelemben

O. Pipek, Péter Pollner, Ágnes Becsei, 2021, Scientia et Securitas.